NFATC2 and melanoma: In addition, inhibition of NFATc2 by AM404 or zoledronic acid, or the GSK-3β inhibitor AR-014418 in association with the EZH2 inhibitor GSK126-induced significant anti-proliferative and pro-apoptotic effects on melanoma cell lines.